BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37848641)

  • 21. Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.
    Lohmann P; Herzog H; Rota Kops E; Stoffels G; Judov N; Filss C; Galldiks N; Tellmann L; Weiss C; Sabel M; Coenen HH; Shah NJ; Langen KJ
    Eur Radiol; 2015 Oct; 25(10):3017-24. PubMed ID: 25813014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2-18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging.
    Stadlbauer A; Prante O; Nimsky C; Salomonowitz E; Buchfelder M; Kuwert T; Linke R; Ganslandt O
    J Nucl Med; 2008 May; 49(5):721-9. PubMed ID: 18413402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.
    Werner JM; Stoffels G; Lichtenstein T; Borggrefe J; Lohmann P; Ceccon G; Shah NJ; Fink GR; Langen KJ; Kabbasch C; Galldiks N
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1889-1901. PubMed ID: 31203420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [
    Henriksen OM; Hansen AE; Muhic A; Marner L; Madsen K; Møller S; Hasselbalch B; Lundemann MJ; Scheie D; Skjøth-Rasmussen J; Poulsen HS; Larsen VA; Larsson HBW; Law I
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4677-4691. PubMed ID: 35907033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.
    Pauleit D; Floeth F; Hamacher K; Riemenschneider MJ; Reifenberger G; Müller HW; Zilles K; Coenen HH; Langen KJ
    Brain; 2005 Mar; 128(Pt 3):678-87. PubMed ID: 15689365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of
    Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI.
    da Silva NA; Lohmann P; Fairney J; Magill AW; Oros Peusquens AM; Choi CH; Stirnberg R; Stoffels G; Galldiks N; Golay X; Langen KJ; Jon Shah N
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1031-1040. PubMed ID: 29478081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of MRI and dynamic FET PET for initial glioma grading.
    Dunet V; Maeder P; Nicod-Lalonde M; Lhermitte B; Pollo C; Bloch J; Stupp R; Meuli R; Prior JO
    Nuklearmedizin; 2014 Aug; 53(4):155-61. PubMed ID: 24737132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
    Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
    Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis.
    Heinzel A; Müller D; Langen KJ; Blaum M; Verburg FA; Mottaghy FM; Galldiks N
    J Nucl Med; 2013 Aug; 54(8):1217-22. PubMed ID: 23785172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.
    Neuner I; Kaffanke JB; Langen KJ; Kops ER; Tellmann L; Stoffels G; Weirich C; Filss C; Scheins J; Herzog H; Shah NJ
    Eur Radiol; 2012 Dec; 22(12):2568-80. PubMed ID: 22777617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
    J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid PET and MR perfusion imaging in brain tumours.
    Filss CP; Cicone F; Shah NJ; Galldiks N; Langen KJ
    Clin Transl Imaging; 2017; 5(3):209-223. PubMed ID: 28680873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.
    Song S; Cheng Y; Ma J; Wang L; Dong C; Wei Y; Xu G; An Y; Qi Z; Lin Q; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1458-1467. PubMed ID: 31919633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.
    Sacconi B; Raad RA; Lee J; Fine H; Kondziolka D; Golfinos JG; Babb JS; Jain R
    J Neurooncol; 2016 Apr; 127(2):287-93. PubMed ID: 26729270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.
    Zhang K; Langen KJ; Neuner I; Stoffels G; Filss C; Galldiks N; Tellmann L; Rota Kops E; Coenen HH; Herzog H; Shah NJ
    Nucl Med Commun; 2014 Mar; 35(3):245-51. PubMed ID: 24240195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.